EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Postoperative complications of endovenous laser obliteration with various pharmacotherapy regimens

Aleksey A. Kamaev, Roman E. Kalinin, Alexander S. Pshennikov, Igor A. Suchkov

I.P. Pavlov Russian Medical Biological Herald · 30.06.2026 · 34 (2) · 169-178

DOI: 10.17816/pavlovj701449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift I.P. Pavlov Russian Medical Biological Herald, online erschienen am 30.06.2026. Verfasst von Aleksey A. Kamaev und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Endovenous laser obliteration (EVLO) is the current standard for surgical treatment of lower extremity varicose veins (LEVV). However, even with high effectiveness of the method, the postoperative period may run with adverse effects of varying clinical significance. The role of postoperative pharmacotherapy in reducing the incidence and severity of complications remains poorly understood and requires further analysis. AIM: To evaluate the frequency, structure, timing of occurrence, and clinical outcomes of postoperative and pharmacotherapeutic complications in patients with LEVV after EVLO with various postoperative management variants. METHODS: A prospective observational study included 173 patients with LEVV (class C2–C6 in the Clinical, Etiological, Anatomical, Pathophysiological (CEAP) classification)) who underwent EVLO. Depending on the postoperative management tactics, the patients were divided into four groups: group 1 — EVLO without drug therapy; group 2 — EVLO + micronized purified flavonoid fraction (MPFF); group 3 — EVLO + sulodexide; group 4 — EVLO + MPFF + sulodexide. Pharmacotherapy was prescribed for 2 months. The follow-up period was 12 months. RESULTS: During the follow-up period, 36 complications were recorded, the most common being hyperpigmentation and secondary telangiectasia. Adverse effects associated with drug therapy were rare, mild and transient, and did not require discontinuation or correction of the prescribed treatment. The incidence of postoperative complications was highest in the isolated EVLO group at 29.5%, 13.9% with monotherapy, and 4.7% with combination drug therapy. CONCLUSION: Pharmacotherapy after EVLO is characterized by a high safety profile and is associated with reduced frequency of postoperative complications. The combined use of MPFF and sulodexide demonstrated the best clinical results without increasing the risk of adverse events.

Zitieren

APA

Kamaev, A. A., Kalinin, R. E., Pshennikov, A. S., & Suchkov, I. A. (2026). Postoperative complications of endovenous laser obliteration with various pharmacotherapy regimens. I.P. Pavlov Russian Medical Biological Herald, 34(2), 169-178. https://doi.org/10.17816/pavlovj701449

Vancouver

Kamaev AA, Kalinin RE, Pshennikov AS, Suchkov IA. Postoperative complications of endovenous laser obliteration with various pharmacotherapy regimens. I.P. Pavlov Russian Medical Biological Herald. 2026;34(2):169-178. doi:10.17816/pavlovj701449

BibTeX
@article{Kamaev2026,
  author = {Kamaev, Aleksey A. and Kalinin, Roman E. and Pshennikov, Alexander S. and Suchkov, Igor A.},
  title = {Postoperative complications of endovenous laser obliteration with various pharmacotherapy regimens},
  journal = {I.P. Pavlov Russian Medical Biological Herald},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {169--178},
  doi = {10.17816/pavlovj701449}
}
Kostenlos starten →